CBD: To Be or Not To Be a Supplement Ingredient; Petition Seeks a Go-ahead From FDA

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

CBD: To Be or Not To Be a Supplement Ingredient; Petition Seeks a Go-ahead From FDA

Darla M. Fera

December 5, 2019 at 08:37 AM EST

The Consumer Healthcare Products Association (CHPA) has petitioned the FDA to “establish a regulatory pathway” to legally market dietary supplements containing cannabidiol (CBD) derived from hemp. It further proposes “that the resulting regulation” require that manufacturers of CBD-containing dietary supplements submit new dietary ingredient (NDI) notifications to the FDA. In... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

CBD: To Be or Not To Be a Supplement Ingredient; Petition Seeks a Go-ahead From FDA

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

CBD: To Be or Not To Be a Supplement Ingredient; Petition Seeks a Go-ahead From FDA

My Research Folders

Related Articles

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT